Danielle Wallace

10PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersHaematological tumoursRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 18, 2026
Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study.

Jia Ruan, Zhengming Chen, Melissa C Larson

|Jan 06, 2026
Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma.

Juan Pablo Alderuccio, Diva Baggio, Sunwoo Han

|Nov 17, 2025
Sun Sets on Rituximab/Gemcitabine/Oxaliplatin as Bispecific Antibodies Rise: The SUNMO Trial.

Danielle S Wallace, Jonathan W Friedberg

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

|Oct 02, 2024
How I treat older patients with relapsed/refractory diffuse large B-cell lymphoma.

Danielle S Wallace, Kah Poh Loh, Carla Casulo

|Aug 22, 2024
Ready, AIM, stop: ibrutinib plus venetoclax in MCL.

Danielle S Wallace, Paul M Barr

Pageof 2

Frequent Collaborators

3 joint publications

Carla Casulo

3 joint publications

Paul M Barr

2 joint publications

Clive S Zent

2 joint publications

Joanna M Rhodes